BMG Pharma s.r.l., as the successor in interest to BMG Pharma LLC of the United States since 2006, specializes in developing, registering and licensing specialty pharmaceutical medical devices and cosmetics.
The company currently focuses on dermatology, gynecology, cancer support therapy and oral health and has emerged as a leader in these specialty areas by collaborating with market leading Partners with highly responsive and innovative solutions to renew and extend product offerings. BMG Pharma's comprehensive services include ready-to-market products, customer specified development programs, disease and incidence data and clinical evidence specific to our customer’s needs.
BMG Pharma has a broad portfolio of ready-to-market products focused on topical inflammation of mucosal and dermal tissue. The existing portfolio is covered by unique delivery systems, packaging and IP protection. With a wide range of active ingredients developed as medical devices the portfolio includes both the prescription, OTX and OTC positioning. BMG Pharma is dedicated to helping patients, pharmacist and physicians by providing valuable and innovative products to the market.
Based in Milan, the Company is privately owned by Management and parties with strategic interests.